CymaBay to Host Key Opinion Leader Meeting on Primary Biliary Cholangitis in New York City
Nov 10, 2016 21:02 pm UTC| Business
NEWARK, Calif., Nov. 10, 2016 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need, including rare and...
The Joint Corp. Reports Third Quarter 2016 Financial Results
Nov 10, 2016 21:01 pm UTC| Business
The Company Added 42 Total Clinics in First Nine Months Raises 2016 Adjusted EBITDA Guidance Appoints John Meloun Chief Financial Officer and Eric Simon Vice President of Franchise Sales and DevelopmentSCOTTSDALE, Ariz.,...
Nov 10, 2016 21:01 pm UTC| Business
MINNEAPOLIS, Nov. 10, 2016 -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases...
Achaogen to Present at the Stifel Healthcare Conference 2016
Nov 10, 2016 21:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2016 -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...
OncoCyte Reports Third Quarter 2016 Financial Results
Nov 10, 2016 21:01 pm UTC| Business
Currently Processing Samples and Analyzing Results in its Lung Cancer Test Study; Continues to Project a Completion Date in Late December Conference Call to Discuss the Results at 5:00 p.m. ET ...
STRATA Skin Sciences Reports Third Quarter 2016 Financial Results
Nov 10, 2016 21:01 pm UTC| Business
Company is cash flow positive for the third quarter Conference call and webcast, today at 4:30 pm Eastern Time HORSHAM, Pa., Nov. 10, 2016 -- (NASDAQ:SSKN) STRATA Skin Sciences, Inc. (“STRATA”) a medical technology...
Pernix Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update
Nov 10, 2016 21:01 pm UTC| Business
Net Revenue Increased 13% Sequentially Over Second Quarter 2016 Prescription Volumes Grew Sequentially and Year-Over-Year for All Three Core Brands, Treximet®, Zohydro ER® with BeadTek™ and Silenor®MORRISTOWN, N.J., Nov. ...